M. Kağıtcı Et Al. , "Does STAT-3 and IL-26 activity have a place in the pathophysiology of endometrioma?," 2025, V3
Kağıtcı, M. Et Al. 2025. Does STAT-3 and IL-26 activity have a place in the pathophysiology of endometrioma?. , V3
Kağıtcı, M., Şentürk, Ş., Mercantepe, T., Dereci Delibaş, D., & Bedir, R., (2025). Does STAT-3 and IL-26 activity have a place in the pathophysiology of endometrioma?. , V3
Kağıtcı, MEHMET Et Al. "Does STAT-3 and IL-26 activity have a place in the pathophysiology of endometrioma?," , V3, 2025
Kağıtcı, MEHMET Et Al. "Does STAT-3 and IL-26 activity have a place in the pathophysiology of endometrioma?." 2025, V3
Kağıtcı, M. Et Al. (2025) . "Does STAT-3 and IL-26 activity have a place in the pathophysiology of endometrioma?." , V3.
@misc{ url={https://avesis.erdogan.edu.tr/ScientificDataShare/Details/8dbc3b3e-7b07-4d1e-ad35-c542b38ff1e6/does-stat-3-and-ıl-26-activity-have-a-place-in-the-pathophysiology-of-endometrioma??isLastVersion=false}, author={MEHMET KAĞITCI Et Al. }, title={Does STAT-3 and IL-26 activity have a place in the pathophysiology of endometrioma?}, publisher={ Recep Tayyip Erdoğan Üniversitesi AVESİS Veri }, year={2025}}